Dupont Jakob bought BOLT
June 10, 2026 · Form 4 insider transaction
Dupont Jakob bought 5,000 shares of Bolt Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
5,000
Price
$0.00
Total value
N/A
InsiderDupont Jakob
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 10, 2026
Filing dateJune 11, 2026
Shares owned after5,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to the option will vest on the earlier of June 9, 2027 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer.